Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.86B | 11.42B | 10.18B | 8.96B | 6.73B | 7.60B | Gross Profit |
2.72B | 2.64B | 2.40B | 1.86B | 1.96B | 2.10B | EBIT |
674.50M | 987.28M | 1.09B | 645.60M | 729.25M | 690.00M | EBITDA |
2.47B | 2.92B | 2.61B | 2.20B | 1.52B | 1.30B | Net Income Common Stockholders |
819.20M | 945.72M | 733.21M | 499.59M | 587.76M | -65.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.77B | 3.64B | 2.99B | 2.59B | 1.82B | 99.99M | Total Assets |
42.17B | 43.53B | 41.85B | 42.90B | 39.13B | 27.35B | Total Debt |
13.07B | 14.00B | 15.07B | 16.75B | 14.80B | 4.53B | Net Debt |
9.30B | 10.44B | 12.26B | 14.17B | 12.98B | 2.71B | Total Liabilities |
22.23B | 23.97B | 23.67B | 25.41B | 22.52B | 11.77B | Stockholders Equity |
17.57B | 17.20B | 15.97B | 15.33B | 14.51B | 13.57B |
Cash Flow | Free Cash Flow | ||||
2.10B | 1.94B | 1.93B | -1.06B | -10.07B | -2.94B | Operating Cash Flow |
2.41B | 2.27B | 2.30B | 2.04B | 2.14B | 738.01M | Investing Cash Flow |
-455.07M | -165.85M | -147.64M | -2.98B | -12.14B | -3.44B | Financing Cash Flow |
-1.49B | -1.37B | -1.90B | 1.74B | 10.07B | 2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥57.35B | 12.74 | 2.51% | 18.84% | 119.23% | ||
79 Outperform | ¥6.20B | 7.35 | 3.31% | -9.85% | -8.43% | ||
71 Outperform | ¥91.21B | 11.26 | 2.85% | 5.77% | 11.61% | ||
69 Neutral | ¥30.27B | 9.78 | 3.48% | 8.60% | 93.71% | ||
66 Neutral | ¥11.80B | 13.09 | 5.25% | 1.05% | 5.32% | ||
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
51 Neutral | ¥4.44B | ― | ― | 28.89% | -2448.94% |